Default: Expert Opinion on Therapeutic Patents

ISSN: 1354-3776

Journal Home

Journal Guideline

Expert Opinion on Therapeutic Patents Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Opinion on Therapeutic Patents is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 88. It has a price of 4000 €. It has an SJR impact factor of 1,291 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,291.

Expert Opinion on Therapeutic Patents focuses its scope in these topics and keywords: patent, inhibitors, ligands, kppotassium, katpand, ischemichypoxicanoxic, injury, improvements, ht, literaturerecent, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Expert Opinion on Therapeutic Patents

1,291

SJR Impact factor

88

H Index

52

Total Docs (Last Year)

208

Total Docs (3 years)

5718

Total Refs

1283

Total Cites (3 years)

203

Citable Docs (3 years)

5.87

Cites/Doc (2 years)

109.96

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


patent, inhibitors, ligands, kppotassium, katpand, ischemichypoxicanoxic, injury, improvements, ht, literaturerecent, loses, modulatorsrecent, nervous, neuroprotection, peripheral, pharmaceutical, potent, potential, progress, histone, general, field, agent, agents, ssulfonylamidine, anticancer, antitumor, battlesfactor, camptothecin, canada’s, central, channels, cyclotides, demethylase, derivatives, developments, diseasesrecent, evaluation,

FAQS